All In MedTech

FDA Clearance Tracker · P140009-S121

Liberta RC™ DBS IPG

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 7, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 7, 2025

Approved

Time to decision

90 days

Received Jun 9, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P140009-S121
Device name
Liberta RC™ DBS IPG
Applicant location
Plano, TX
Received
Jun 9, 2025
Decided
Sep 7, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P140009

Device type

Device class
Class III

Every decision under product code MHY

FDA's approval statement

As written in FDA's record.

Approval for four alternate components which will be utilized on Printed Circuit Board Assembly (PCBA) for Abbott’s EternaTM SCS and Liberta RCTM Implantable Pulse Generator.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.